224
Views
64
CrossRef citations to date
0
Altmetric
Research Article

LIPOSOME-INCORPORATED SANTOLINA INSULARIS ESSENTIAL OIL: PREPARATION, CHARACTERIZATION AND IN VITRO ANTIVIRAL ACTIVITY

, , , , , , & show all
Pages 73-90 | Published online: 30 Apr 2001

REFERENCES

  • Erlich K. S., Mills J., Chatis P., Mertz G. J., Bush D. F., Follansbee S. E., Grant R. M., Crumpacker C. S. Acyclovir-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 293–296
  • Nugier F., Collins J. N., Ayamard M., Langlois M. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol 1992; 36: 1–12
  • Safrin S., Kemmerly S., Plotkin B., Smith T., Weissbach N., De Veranez D., Phan L. D., Cohn D. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 1994; 169: 193–196
  • Hoch B. S., Shahamehdi S. J., Louis B. M., Lipner H. I. Foscarnet alters antidiuretic hormone-mediated transport. Antimicrob Agents Chemother 1995; 39: 2008–2012
  • Ernst M. E., Franey R. J. Acyclovir- and ganciclovir-induced neurotoxicity. The Ann Pharmacother 1998; 32: 111–113
  • Hayashi K., Hayashi T., Morita N. Mechanism of action of the antiherpes virus biflavone ginketin. Antimicrob Agents Chemother 1992; 36: 1890–1893
  • Hayashi K., Hayashi T., Otsuka H., Takeda Y. Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir. J Antimicrob Chemother 1997; 39: 821–824
  • Nagai T., Moriguchi R., Suzuki Y., Yamada H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antiviral Res 1995; 26: 11–25
  • Andersen D. O., Weber N. D., Wood S. G., Hughes B. G., Murray B. K., North J. A. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res 1991; 16: 185–196
  • Sydiskis R. J., Owen D. G., Lohr J. L., Rosler K. H., Blomster R. N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 1991; 35: 2463–2466
  • Meruelo D., Lavie G., Lavie D. Therapeutic agents with dramatical antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc of the National Academy of Science. USA 1988; 5230–5234, 85
  • Schinazi R. F., Chu C. K., Babu J. R. Anthraquinones as a new class of agents against human immunodeficiency virus. Antiviral Res 1990; 13: 265–272
  • Giner R. M., Rios J. L., Villar A. Inhibitory effects of Santolina chamaecyparissus extracts against spasmogen agonists. J Ethnopharmacol. 1989; 27: 1–6
  • Silvan A. M., Abad M. J., Bermejo P., Sollhuber M., Villar A. Antiinflammatory activity of coumarins from Santolina oblongifolia. J Nat Prod 1996; 59: 1183–1185
  • Sacchetti G., Romagnoli C., Mares D., Bonsignore L., Poli F. Antibacterial effects of the essential oil of Santolina insularis (Genn. Ex Fiori) Arr. (Asteraceae). Biomedical Letters 1995; 52: 191–195
  • Poli F., Bonignore L., Loy G., Sacchetti G., Ballero M. Comparison between the essential oils of Santolina insularis (Genn. Ex Fiori) Arrigoni and Santolina corsica (Jord. et Fourr.) from the island of Sardinia (Italy). J Ethnopharmacol 1997; 56: 201–208
  • Ribeiro A., Arnaud P., Frazao S., Venâncio F., Chaumeil J. C. Development of vegetable extracts by microencapsulation. J Microencapsul 1997; 14: 735–742
  • Jalšenjak V., Peljnjak S., Kuštrak D. Microcapsules of Sage oil: essential oil content and antimicrobial activity. Pharmazie 1987; 42: 419–420
  • Tasic L., Sekesan V., Sekulovic D., Ristic M. Influence of the method for the preparation of essential oil/β-cyclodextrin complexes on the stability of selected oil components. Proc of the 1st World Meeting on Pharmaceutics Bio-pharmaceutics Pharmaceutical Technology. APGI, Chatenay MalabryFrance 1995; 629–630
  • Szoka F. C. The future of liposomal drug delivery. Biotecnol Appl Biochem 1990; 12: 496–500
  • Lasic D. D. Liposomes. From Physics to Applications. Elsevier, Amsterdam 1993
  • Szebeni J., Wahl S. M., Betageri G. V., Wahl L. M., Gartner S., Popovic M., Parker R. J., Black C. D. V., Weinstein J. N. Inhibition of HIV-1 in monocyte/macrophage cultures by 2′,3′-dideoxycytidine-5′-triphosphate, free and in liposomes. AIDS. Res Hum Retroviruses 1990; 6: 691–702
  • Gümbel H. O. C., Rückert D. G., Cinatl J., Rabenau H., Doerr H. W., Ohrloff C. In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet. German J Ophtalmol 1994; 3: 5–8
  • Dusserre N., Lessard C., Paquette N., Perron S., Poulin L., Tremblay M., Beauchamp D., Désormaux A., Bergeron M. G. Encapsulation of foscarnet in liposomes modifies intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS 1995 9: 833–841
  • Popescu M. C., Swenson C. E., Ginsberg R. S. Liposome mediated treatment of viral, bacterial, and protozoal infections. Liposomes: from biophysics to therapeutics, M. J. Ostro. Dekker, Inc., New York 1987; 219–225
  • Gangemi J. D., Nachtigal M., Barnhart D., Krech L., Jani P. Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with Influenza or Herpes simplex virus. J Infect Dis 1987; 155: 510–517
  • Le Bourlais C., Chevanne F., Ropert P., Bretagne G., Zia H., Sado P. A., Needham T., Leverge R. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits. J Microencapsul 1996; 13: 473–480
  • Kuppermann B. D., Assil K. K., Vuong C., Besen G., Wiley C. A., De Clercq E., Bergeron L. G., Connor J. D., Pursley M., Munguia D., Freeman W. R. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine for long-acting therapy of viral retinitis. J Infect Dis 1996; 173: 18–23
  • Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986; 89: 271–277
  • Szoka F. C., Chu C. J. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of Herpes Simplex virus type 2 replication by encapsulation in liposomes. Antimicrob Agents Chemother 1988; 32: 858–864
  • Chu C. J., Szoka F. C. Antiviral activity and pharmacokinetics of liposome-encapsulated phosphonoformate in Rauscher murine leukemia virus-infected mice. J Liposome Res 1992; 2: 67–92
  • Hofland H. E. J., van der Geest R., Bodde H. E., Junginger H. E., Bouwstra J. A. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 1994; 11: 659–664
  • De Logu A., Fadda A. M., Anchisi C., Maccioni A. M., Sinico C., Schivo M. L., Alhaique F. Miconazole and ketoconazole in different phospholipid formulations: effects on in vitro activity. J Antimicrob Chemot 1997; 40: 889–893
  • Fadda A. M., Baroli B., Maccioni A. M., Valenti D., Sinico C., Alhaique F. Phospholipid-detergent systems: effect of polysorbates on the release of liposomal caffeine. Il Farmaco 1998; 53: 650–654

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.